Updating the approach to Crohn's disease.

  title={Updating the approach to Crohn's disease.},
  author={S B Hanauer},
  journal={Hospital practice},
  volume={34 8},
  pages={77-8, 81-3, 87-93; discussion 94}
Recognizing clinical and pathologic scenarios, rather than ordering definitive tests, is still the basis for diagnosis of Crohn's disease. Steroids, salicylates, immunomodulating agents, and surgery remain the focus of treatment. The advent of infliximab, however, offers a new therapeutic option for patients with refractory disease. 

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-4 of 4 extracted citations

Budesonide (Entocort® EC Capsules)

Drugs • 2012
View 3 Excerpts
Highly Influenced

The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology • 2013
View 1 Excerpt

Home study course: spring 2001.

Journal of lower genital tract disease • 2001

Similar Papers

Loading similar papers…